glutethimide Doriden withdrawn
Selected indexed studies
- Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer. (Urology, 1996) [PMID:8560680]
- Use of aminoglutethimide in the treatment of pituitary-dependent hyperadrenocorticism in the dog. (J Small Anim Pract, 2002) [PMID:11924551]
- The adrenocortical system responds slowly to removal of corticosterone in the absence of concurrent stress. (Endocrinology, 1989) [PMID:2539968]
_Worker-drafted node — pending editorial review._
Connections
glutethimide Doriden withdrawn is a side effect of
Sources
- Hormone and antihormone withdrawal: implications for the management of androgen-independent prostate cancer. (1996) pubmed
- Use of aminoglutethimide in the treatment of pituitary-dependent hyperadrenocorticism in the dog. (2002) pubmed
- The adrenocortical system responds slowly to removal of corticosterone in the absence of concurrent stress. (1989) pubmed
- Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients. (1991) pubmed
- Pancytopenia induced by aminoglutethimide in the treatment of breast cancer. (1978) pubmed